Skip to main content

Karma Biotechnologies

Torrance, United States

Karma Biotechnologies is solving autoimmunity, allergies, and food sensitivities with our Xavine™ precision immunotherapy platform.

$31K raised
May 2023
Seed

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Karma Biotechnologies

How much funding has Karma Biotechnologies raised?
Karma Biotechnologies has raised $31K in total funding. The most recent round was Seed. The last funding was announced in May 2023.
Who are Karma Biotechnologies's investors?
Karma Biotechnologies's investors include Gaingels, Khosla Ventures, Presight Capital, SOSV, Calm Ventures.
Where is Karma Biotechnologies headquartered?
Karma Biotechnologies is headquartered in Torrance, United States.
What does Karma Biotechnologies do?
Karma Biotechnologies is solving autoimmunity, allergies, and food sensitivities with our Xavine™ precision immunotherapy platform.
What stage is Karma Biotechnologies at?
Karma Biotechnologies is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Karma Biotechnologies — Funding & Investors." VCBacked, May 31, 2023, https://www.vcbacked.co/company/karma-biotechnologies. Accessed July 2, 2026.
APA
VCBacked. (2023). Karma Biotechnologies — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/karma-biotechnologies
Wikipedia (cite web)
{{cite web |title=Karma Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/karma-biotechnologies |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .